HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Church & Dwight Continues Organic Growth, Starts Price Hikes Due To Tariffs

This article was originally published in The Rose Sheet

Executive Summary

Third-quarter organic sales jumped 4.7%, ahead of analyst expectations, on volume growth and product mix and pricing. However, due to commodity pressures from trade tariffs, it will raise prices across a third of its portfolio, starting in the current quarter.

You may also be interested in...



C&D Targets Innovation From Revenue Growth On Consumer Health Price Hikes

CEO says higher revenues on consumer health product sales partly due to higher prices should go to innovation rather than advertising. During Q2 earnings briefing, analysts suggest competitors will boost promotions and hamper C&D’s 4% organic growth outlook for 2019.

Church & Dwight Expects 3.5% Growth In 2019 On Line Extensions, Price Increases

Church & Dwight estimates 3.5% organic sales growth in 2019 on innovations including Orajel Toothache Strips as well as organic gummy vitamins and "world’s first flossing toothbrush.” Reporting weaker-than-expected Q$ earnings, it plans to raise prices on more product categories in 2019.

Higher Consumer Health Price Tags Ahead As Chinese Import Tariff Increases

Additional tariffs on Chinese imports of ingredients needed for dietary supplements in addition to active ingredients and excipients used in OTC drugs will increase manufacturers' costs even if they arrange to receive ingredients from firms in the US of other countries. The American Herbal Products Association told USTR that firms impacted by the additional tariff "will be faced with the need to either increase prices and thus risk sales losses, absorb additional costs by reducing profit margins, or discontinue products; each of these options risks economic harm to these companies and job losses to their employees."

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS122405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel